About Us | Contact

Jeffrey J Connaire Investigator

Nephrology Fairview Southdale Hospital NPI1710931449
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$9,932.72
from 33 payments in the last 6 years

Total Cash or Cash Equivalent

$5,885.32
from 8 payments in the last 6 years

Total In-kind Items & Services

$4,047.40
from 25 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
02/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4725.00 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 738908939
11/05/2019 General (Non-Research) In-kind items and services Food and Beverage $201.89 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 709102925
11/05/2019 General (Non-Research) In-kind items and services Food and Beverage $36.22 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 709102815
11/05/2019 General (Non-Research) In-kind items and services Food and Beverage $113.46 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 709099503
01/30/2019 Research In-kind items and services $23.51 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 669962809
01/30/2019 Research In-kind items and services $23.02 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 669962675
01/30/2019 Research In-kind items and services $177.04 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 669958439
01/30/2019 Research In-kind items and services $231.44 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 669957501
01/30/2019 Research In-kind items and services $128.77 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 669956803
01/30/2019 Research In-kind items and services $67.49 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 669956801
01/30/2019 Research In-kind items and services $909.08 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 669954221
10/22/2018 General (Non-Research) In-kind items and services Food and Beverage $195.37 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 618641683
10/22/2018 General (Non-Research) In-kind items and services Food and Beverage $43.55 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 618641367
10/22/2018 General (Non-Research) In-kind items and services Food and Beverage $82.43 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 618637777
10/22/2018 General (Non-Research) In-kind items and services Travel and Lodging $48.19 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 618637773
04/11/2018 Research In-kind items and services $238.20 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 593103709
04/11/2018 Research In-kind items and services $620.05 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 593103699
04/11/2018 Research In-kind items and services $120.47 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 593103213
04/11/2018 Research In-kind items and services $155.68 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 593103211
04/11/2018 Research In-kind items and services $68.76 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 593103209
04/11/2018 Research In-kind items and services $31.45 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P
Payment Record ID 593103203
12/15/2017 General (Non-Research) In-kind items and services Food and Beverage $144.73 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 479076187
12/15/2017 General (Non-Research) In-kind items and services Food and Beverage $75.69 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 479076183
12/15/2017 General (Non-Research) In-kind items and services Food and Beverage $38.70 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 479076180
09/07/2016 General (Non-Research) In-kind items and services Food and Beverage $54.41 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 388614582
09/07/2016 General (Non-Research) Cash or cash equivalent Travel and Lodging $436.88 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 388614556
09/07/2016 General (Non-Research) In-kind items and services Travel and Lodging $217.80 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 388614524
12/12/2016 Research Cash or cash equivalent $81.36 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase 3 randomized, open label sponsor blind , active controlled, parallel group, multi center, event driven study in non dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared t
Payment Record ID 386862566
12/12/2016 Research Cash or cash equivalent $36.37 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase 3 randomized, open label sponsor blind , active controlled, parallel group, multi center, event driven study in non dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared t
Payment Record ID 386862534
12/12/2016 Research Cash or cash equivalent $85.53 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase 3 randomized, open label sponsor blind , active controlled, parallel group, multi center, event driven study in non dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared t
Payment Record ID 386862422
12/12/2016 Research Cash or cash equivalent $35.13 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase 3 randomized, open label sponsor blind , active controlled, parallel group, multi center, event driven study in non dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared t
Payment Record ID 386862394
12/12/2016 Research Cash or cash equivalent $66.76 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase 3 randomized, open label sponsor blind , active controlled, parallel group, multi center, event driven study in non dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared t
Payment Record ID 386862366
12/01/2016 Research Cash or cash equivalent $418.29 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase 3 randomized, open label sponsor blind , active controlled, parallel group, multi center, event driven study in non dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared t
Payment Record ID 386862282
;